Alaunos Therapeutics, Inc. (TCRT) Reports In-Line Q2 EPS

Alaunos Therapeutics, Inc. (NASDAQ: TCRT) reported Q2 EPS of ($0.04), in-line with the analyst estimate of ($0.04).

For earnings history and earnings-related data on Alaunos Therapeutics, Inc. (TCRT) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• Flexsteel (FLXS) Tops Q4 EPS by 24c, Beats on Revenue; Offers Q1 Revenue Guidance